Paid Clinical Trials Dayton
Discover 1,139 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
Suicide Risk ReductionStepped Approach to Reducing Risk of Suicide in Primary Care
Sponsor:
Cynthia Fontanella
Location:
Code:
NCT06018285
Conditions
Suicidal Ideation
Suicide, Attempted
Suicide Prevention
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
Stepped Approach to Reducing Risk of Suicide in Primary Care
Observational StudyCirculating Tumor DNA Exposure in Peripheral Blood
Sponsor:
Quantgene Inc.
Location:
Code:
NCT03517332
Conditions
Colorectal Cancer
Pancreatic Adenocarcinoma
Gastric Cancer
Hepatocellular Carcinoma
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
IanalumabA Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05985915
Conditions
Sjogrens Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ianalumab (VAY736)
Placebo
PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516952
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Carillon SystemThe EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
Sponsor:
Cardiac Dimensions, Inc.
Location:
Code:
NCT03142152
Conditions
Functional Mitral Regurgitation
Heart Failure
Mitral Valve Insufficiency
Heart Diseases
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carillon Mitral Contour System
Guideline Directed Heart Failure Medication
Oral & Injectable BuprenorphineA Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Sponsor:
VA Office of Research and Development
Location:
Code:
NCT04375033
Conditions
Opioid Use Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sublingual buprenorphine with naloxone
Injectable subcutaneous buprenorphine
EmpasiprubartA Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
Sponsor:
argenx
Location:
Code:
NCT06284954
Conditions
Dermatomyositis
Myositis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Empasiprubart IV
Placebo IV
VAX-31A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Sponsor:
Vaxcyte, Inc.
Location:
Code:
NCT06720038
Conditions
Pneumococcal Vaccines
Eligibility Criteria
Sex: All
Age: 42 - 70+
Healthy Volunteers: Accepted
Interventions
0.5 mL of the low dose VAX-31
0.5 mL of the mid dose VAX-31
0.5 mL of the high dose VAX-31
0.5 mL dose of PCV20
Neoadjuvant Chemotherapy & TrastuzumabStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Sponsor:
NSABP Foundation Inc
Location:
Code:
NCT03412643
Conditions
HER2-negative Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Doxorubicin
Cyclophosphamide
Weekly Paclitaxel
Trastuzumab
Pertuzumab